Is ribavirin actually useful for Genotype 1 cirrhotic patients who receive DAAs combination? An updated meta-analysis of randomized controlled trials - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Hepatology Année : 2015

Is ribavirin actually useful for Genotype 1 cirrhotic patients who receive DAAs combination? An updated meta-analysis of randomized controlled trials

(1) , (2) , (3) , (3) , (2) , (4) , (5) , (6) , (7) , (8, 9) , (10) , (11)
1
2
3
4
5
6
7
8
9
10
11
Fichier non déposé

Dates et versions

hal-03946474 , version 1 (19-01-2023)

Identifiants

  • HAL Id : hal-03946474 , version 1

Citer

Vincent Di Martino, Carine Richou, Jean Paul Cervoni, Delphine Weil, Claire Vanlemmens, et al.. Is ribavirin actually useful for Genotype 1 cirrhotic patients who receive DAAs combination? An updated meta-analysis of randomized controlled trials. Hepatology, 2015, 62 (1, SI), pp.796A-797A. ⟨hal-03946474⟩
0 Consultations
0 Téléchargements

Partager

Gmail Facebook Twitter LinkedIn More